The rise of copyright’s blockbuster initially fueled a boom for the drug industry, but recent developments present a complicated outlook for shareholders. Off-patent competitors are eating into profits, and https://minarywm673574.dgbloggers.com/41605743/sildenafil-and-the-pharmaceutical-industry-a-risky-play